EFFECT OF TENOFOVIR ALAFENAMIDE FUMARATE (TAF) PROPHYLAXIS FOR HEPATITIS B VIRUS REACTIVATION IN HBV-INFECTED INDIVIDUALS, WHO RECEIVED CHEMO/IMMUNOSUPPRESSIVE THERAPY | AVESİS

Acibadem Mehmet Ali Aydinlar University Research Information System

EFFECT OF TENOFOVIR ALAFENAMIDE FUMARATE (TAF) PROPHYLAXIS FOR HEPATITIS B VIRUS REACTIVATION IN HBV-INFECTED INDIVIDUALS, WHO RECEIVED CHEMO/IMMUNOSUPPRESSIVE THERAPY

AASLD_TASL Digital Hepatology Connect, 15 - 16 January 2021, pp.3-4

Publication Type: Conference Paper / Full Text
Page Numbers: pp.3-4